Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Direct-to-consumer (DTC) personal genomic testing (PGT) allows individuals to learn about their genetic makeup without going through a physician, but some consumers share their results with their primary care provider (PCP). OBJECTIVE: To describe the characteristics and perceptions of DTC PGT consumers who discuss their results with their PCP. DESIGN: Longitudinal, prospective cohort study. SETTING: Online survey before and 6 months after results. PARTICIPANTS: DTC PGT consumers. MEASUREMENTS: Consumer satisfaction with the DTC PGT experience; whether and, if so, how many results could be used to improve health; how many results were not understood; and beliefs about the PCP's understanding of genetics. Participants were asked with whom they had discussed their results. Genetic reports were linked to survey responses. RESULTS: Among 1026 respondents, 63% planned to share their results with a PCP. At 6-month follow-up, 27% reported having done so, and 8% reported sharing with another health care provider only. Common reasons for not sharing results with a health care provider were that the results were not important enough (40%) or that the participant did not have time to do so (37%). Among participants who discussed results with their PCP, 35% were very satisfied with the encounter, and 18% were not at all satisfied. Frequently identified themes in participant descriptions of these encounters were actionability of the results or use in care (32%), PCP engagement or interest (25%), and lack of PCP engagement or interest (22%). LIMITATION: Participants may not be representative of all DTC PGT consumers. CONCLUSION: A comprehensive picture of DTC PGT consumers who shared their results with a health care provider is presented. The proportion that shares results is expected to increase with time after testing as consumers find opportunities for discussion at later appointments or if results become relevant as medical needs evolve. PRIMARY FUNDING SOURCE: National Institutes of Health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
Ware, J. E., & Gandek, B. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00081-x · Cited by 2,605
Physician-patient communication in the primary care office: a systematic review.
Beck, R., Daughtridge, R., & Sloane, P. D. (2002) · PubMed · Cited by 1,070
Linking primary care performance to outcomes of care.
Safran, D. G., Taira, D. A., Rogers, W. H., Kosinski, M. R., Ware, J. E., & Tarlov, A. R. (1998) · PubMed · Cited by 877
Predictors of patient satisfaction
Jackson, J. L., Chamberlin, J., & Kroenke, K. (2001) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00164-7 · Cited by 861
Letting the Genome out of the Bottle — Will We Get Our Wish?
Hunter, D. J., Khoury, M. J., & Drazen, J. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0708162 · Cited by 357
Pinkhasov, R. M., Wong, J., Kashanian, J., Lee, M., Samadi, D. B., Pinkhasov, M. M., & Shabsigh, R. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02290.x · Cited by 327
Educating health-care professionals about genetics and genomics
Guttmacher, A. E., Porteous, M. E., & McInerney, J. D. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2007 · Cited by 298
Janssens, A. C. J. W., Gwinn, M., Bradley, L. A., Oostra, B. A., van Duijn, C. M., & Khoury, M. J. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.020 · Cited by 278
An Unwelcome Side Effect of Direct-to-Consumer Personal Genome Testing: Raiding the Medical Commons
McGuire, A. L., & Burke, W. (2008) · JAMA · doi:10.1001/jama.2008.803 · Cited by 250
Unmet expectations for care and the patient-physician relationship
Bell, R. A., Kravitz, R. L., Thom, D., Krupat, E., & Azari, R. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.10319.x · Cited by 235
Research works printed but not linked: 3
- Ebell MH, 2008, Am Fam Physician, 78, 501
- Safran DG, 1998, J Fam Pract, 47, 213
- Beck RS, 2002, J Am Board Fam Pract, 15, 25
Cited by
Medical Marketing in the United States, 1997-2016
Schwartz, L. M., & Woloshin, S. (2019) · JAMA · doi:10.1001/jama.2018.19320 · Cited by 379
Roberts, J. S., Gornick, M. C., Carere, D. A., Uhlmann, W. R., Ruffin, M. T., & Green, R. C. (2017) · Public Health Genomics · doi:10.1159/000455006 · Cited by 166
Self-citationDirect-to-Consumer Genetic Testing: Value and Risk
Majumder, M. A., Guerrini, C. J., & McGuire, A. L. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-070119-114727 · Cited by 116
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening
Offit, K., Tkachuk, K. A., Stadler, Z. K., Walsh, M. F., Diaz-Zabala, H. J., Levin, J. D., Steinsnyder, Z., Ravichandran, V., Sharaf, R., Frey, M. K., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02010 · Cited by 101
Primary Care Physicians’ Knowledge, Attitudes, and Experience with Personal Genetic Testing
Haga, S. B., Kim, E. S., Myers, R. A., & Ginsburg, G. S. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9020029 · Cited by 99
Rubanovich, C. K., Cheung, C., Mandel, J., & Bloss, C. S. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy170 · Cited by 100
Stewart, K. F. J., Wesselius, A., Schreurs, M. A. C., Schols, A. M. W. J., & Zeegers, M. P. (2018) · Journal of Community Genetics · doi:10.1007/s12687-017-0310-z · Cited by 89
Views Of Primary Care Providers On Testing Patients For Genetic Risks For Common Chronic Diseases
Hauser, D., Obeng, A. O., Fei, K., Ramos, M. A., & Horowitz, C. R. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1548 · Cited by 95
Sequencing Newborns:A Call for Nuanced Use of Genomic Technologies
Johnston, J., Lantos, J. D., Goldenberg, A. J., Chen, F., Parens, E., Koenig, B. A., & members of the NSIGHT Ethics and Policy Advisory Board (2018) · The Hastings Center Report · doi:10.1002/hast.874 · Cited by 133
American College of Physicians Ethics Manual: Seventh Edition
Sulmasy, L. S., & Bledsoe, T. A. (2019) · Annals of Internal Medicine · doi:10.7326/m18-2160 · Cited by 116
Whitley, K. V., Tueller, J. A., & Weber, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030768 · Cited by 104
“Physicians are often the first healthcare professional with whom patients want to discuss genetic test results; however, many practicing physicians who have not been trained in genomics in medical school do not feel prepared to use or interpret genetic test results [90,91].”
BackgroundCarroll, J. C., Allanson, J. E., Morrison, S., Miller, F. A., Wilson, B. J., Permaul, J., & Telner, D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01189 · Cited by 94
Genomic sequencing in clinical practice: applications, challenges, and opportunities
Krier, J. B., Kalia, S. S., & Green, R. C. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.3/jkrier · Cited by 82
Self-citationLemke, A. A., Selkirk, C. G., Glaser, N. S., Sereika, A., Wake, D. T., Hulick, P. J., & Dunnenberger, H. M. (2017) · Personalized Medicine · doi:10.2217/pme-2017-0036 · Cited by 71
Open sharing of genomic data: Who does it and why?
Haeusermann, T., Greshake, B., Blasimme, A., Irdam, D., Richards, M., & Vayena, E. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177158 · Cited by 68
Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
Lemke, A., Hulick, P., Wake, D. T., Wang, C., Sereika, A., Yu, K., Glaser, N., & Dunnenberger, H. (2018) · Pharmacogenomics (London) · doi:10.2217/pgs-2017-0191 · Cited by 61
Zoltick, E. S., Linderman, M. D., McGinniss, M. A., Ramos, E., Ball, M. P., Church, G. M., Leonard, D. G. B., Pereira, S., McGuire, A. L., Caskey, C. T., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0619-9 · Cited by 66
Self-citationGenetic Testing in Clinical Settings
Franceschini, N., Frick, A., & Kopp, J. B. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.02.351 · Cited by 65
Rafi, I., Crinson, I., Dawes, M. G., Rafi, D., Pirmohamed, M., & Walter, F. M. (2020) · Journal of Community Genetics · doi:10.1007/s12687-020-00468-2 · Cited by 54
(2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002020 · Cited by 54
Koeller, D. R., Uhlmann, W. R., Carere, D. A., Green, R. C., Roberts, J. S., & for the PGen Study Group (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0106-7 · Cited by 52
Self-citationMN, W., L, J., JW, H., KS, R., J, T., AT, H., & CF, W. (2021) · BMJ · doi:10.1136/bmj.n214 · Cited by 51
Physicians’ perspectives on receiving unsolicited genomic results
Pet, D. B., Holm, I. A., Williams, J. L., Myers, M. F., Novak, L. L., Brothers, K. B., Wiesner, G. L., & Clayton, E. W. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0047-z · Cited by 50
Consumer use and response to online third‐party raw DNA interpretation services
Wang, C., Cahill, T. J., Parlato, A., Wertz, B., Zhong, Q., Cunningham, T. N., & Cummings, J. J. (2017) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.340 · Cited by 45
“Consistent with prior literature, approximately 30% of consumers in this study report sharing their raw DNA interpretation results with medical professionals (Darst et al., 2014; van der Wouden et al., 2016).”
ResultPersonal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study
Gray, S. W., Gollust, S. E., Carere, D. A., Chen, C. A., Cronin, A. M., Kalia, S. S., Rana, H. Q., Ruffin, M. T., Wang, C., Roberts, J. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.1503 · Cited by 43
Self-citationHall, J. A., Gertz, R., Amato, J., & Pagliari, C. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.75 · Cited by 40
Hayward, J., McDermott, J. H., Qureshi, N., & Newman, W. G. (2021) · Pharmacogenomics · doi:10.2217/pgs-2021-0032 · Cited by 44
Nelson, S. C., & Fullerton, S. M. (2018) · Journal of Genetic Counseling · doi:10.1007/s10897-018-0217-9 · Cited by 37
Kaphingst, K. A., Kohlmann, W. K., Chambers, R. L., Goodman, M. S., Bradshaw, R. L., Chan, P. A., Chavez‐Yenter, D., Colonna, S. V., Espinel, W., Everett, J. N., et al. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06489-y · Cited by 44
Nolan, J. J., & Ormondroyd, E. (2023) · Clinical Genetics · doi:10.1111/cge.14332 · Cited by 36
Gollust, S. E., Gray, S. W., Carere, D. A., Koenig, B. A., Lehmann, L. S., McGuire, A., Sharp, R. R., Spector‐Bagdady, K., Wang, N., Green, R. C., et al. (2017) · Milbank Quarterly · doi:10.1111/1468-0009.12262 · Cited by 38
Self-citationRoosan, D., Hwang, A., & Roosan, M. R. (2020) · The Pharmacogenomics Journal · doi:10.1038/s41397-020-00182-9 · Cited by 40
Guerrini, C. J., Robinson, J. O., Bloss, C. S., Brooks, W. B., Fullerton, S. M., Kirkpatrick, B. E., Lee, S. S., Majumder, M. A., Pereira, S., Schuman, O., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.01.013 · Cited by 33
Chokoshvili, D., Vears, D. F., & Borry, P. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.02.006 · Cited by 38
Diet and exercise changes following direct-to-consumer personal genomic testing
for the PGen Study Group, Nielsen, D. E., Carere, D. A., Wang, C., Roberts, J. S., & Green, R. C. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0258-1 · Cited by 34
Self-citationAustralians’ views and experience of personal genomic testing: survey findings from the Genioz study
Savard, J., Hickerton, C. L., Tytherleigh, R., Terrill, B., Turbitt, E., Newson, A. J., Wilson, B. J., Gray, K. M., Gaff, C., Middleton, A., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-018-0325-x · Cited by 30
“Previous labeling of PGTs as either health- or nonhealth-related are no longer sufficient due in part to the increasing after-market applications that allow people to perform further analysis on their raw data [31].”
BackgroundHsieh, V., Braid, T., Gordon, E. S., & Hercher, L. (2020) · Journal of Genetic Counseling · doi:10.1002/jgc4.1310 · Cited by 28
“Numerous studies have shown that physicians are not well equipped, and lack both knowledge and time, to address the counseling needs of DTC-GT consumers (Bernhardt et al., 2013; Powell et al., 2012; van der Wouden et al., 2016).”
BackgroundHealth Literacy and the Desire to Manage One's Own Health
Tolan, N. V. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2019.11.007 · Cited by 24
Allen, C. G., Gabriel, J. L., Flynn, M. A., Cunningham, T. N., & Wang, C. (2018) · Translational Behavioral Medicine · doi:10.1093/tbm/ibx009 · Cited by 24
Smit, A. K., Newson, A. J., Keogh, L. A., Best, M. C., Dunlop, K. L. A., Vuong, K., Kirk, J., Butow, P. N., Trevena, L. J., & Cust, A. E. (2019) · BJGP Open · doi:10.3399/bjgpopen18x101633 · Cited by 27
Yin, Z., Song, L., Clayton, E. W., & Malin, B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238644 · Cited by 27
“Given the level of concern among health care providers about DTC health-related results [22, 24, 58] and the many studies of individuals’ views about these tests [59, 60], the level of spontaneous discussion of the test results offered by 23andMe was surprisingly low even after 2017 when that company was once again pe…”
Weedon, M. N., Jackson, L., Harrison, J. W., Ruth, K. S., Tyrrell, J., Hattersley, A. T., & Wright, C. F. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/696799 · Cited by 19
Physician Experience with Direct-To-Consumer Genetic Testing in Kaiser Permanente
Jonas, M. C., Suwannarat, P., Burnett‐Hartman, A. N., Carroll, N. M., Turner, M., Janes, K., Truong, C., Blum‐Barnett, E., Aziz, N., & McGlynn, E. A. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9040047 · Cited by 23
“These results may impact total visits, time spent in discussion within a visit, and patient satisfaction with the encounter [36,43,44].”
BackgroundResultInfluentialThe Deceptive Appeal of Direct-to-Consumer Genetics
Burke, W., & Trinidad, S. B. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0257 · Cited by 19
Patients Armed With Their Own Genetic Data Raise Tough Questions
Storrs, C. (2018) · Health Affairs · doi:10.1377/hlthaff.2018.0364 · Cited by 17
Yu, M. W. C., Fung, J. L. F., Ng, A. P. P., Li, Z., Lan, W., Chung, C. C. Y., Li, Y., Liu, Y., Chung, B. H., & Wong, W. C. W. (2021) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1702 · Cited by 17
Cernat, A., Bashir, N. S., & Ungar, W. J. (2022) · Journal of Community Genetics · doi:10.1007/s12687-022-00582-3 · Cited by 23
Trends in patients’ overall satisfaction with healthcare delivery in Accra, Ghana
Odonkor, S. T., Frimpong, C. A., Duncan, E., & Odonkor, C. J. A. (2019) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v11i1.1884 · Cited by 16
“To achieve our objective, we sought to answer four main questions: (1) What are the satisfaction levels of patients receiving healthcare service? (2) Are there differences in service experiences of healthcare satisfaction between insured and non-insured patients? (3) What are the key factors that influence patients’ o…”
BackgroundUpdating the landscape of direct-to-consumer pharmacogenomic testing
Filipski, K. K., Murphy, J., & Helzlsouer, K. J. (2017) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s140461 · Cited by 15
“9,10 However, direct-to-consumer testing has been marred with controversy.”
Regulation of Internet-based Genetic Testing: Challenges for Australia and Other Jurisdictions
Tiller, J. M., & Lacaze, P. A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00024 · Cited by 15
“Public Underst Sci (2015) 24(6):731–50.”
BackgroundRegulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and Opportunities
Offit, K., Sharkey, C. M., Green, D., Wu, X., Trottier, M., Hamilton, J. G., Walsh, M. F., Dandiker, S., Belhadj, S., Lipkin, S. M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00995 · Cited by 17
Genetic Testing: Challenges and Changes in Testing for Hereditary Cancer Syndromes
King, E., & Mahon, S. M. (2017) · Clinical journal of oncology nursing · doi:10.1188/17.cjon.589-598 · Cited by 14
Ethical Considerations in the Implementation of Nutrigenetics/Nutrigenomics
Hurlimann, T., Robitaille, J., Vohl, M., & Godard, B. (2016) · Personalized Medicine · doi:10.2217/pme-2016-0035 · Cited by 14
Be Ready to Talk With Parents About Direct-to-Consumer Genetic Testing
Clayton, E. W. (2019) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2019.5006 · Cited by 13
Cohidon, C., Cardinaux, R., Cornuz, J., Chenal, R., Desvergne, B., Guessous, I., Cerqui, D., & Widmer, D. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01428-6 · Cited by 16
“If yes, with your GP?”
BackgroundPARC report: A Perspective on the state of Clinical Pharmacogenomics Testing
Eichmeyer, J. N., Rogers, S. L., Formea, C. M., Giri, J., Jones, J. S., Schnettler, E. K., Schmidlen, T., Glogowski, E., & Kurz, R. N. (2020) · Pharmacogenomics · doi:10.2217/pgs-2019-0193 · Cited by 11
Charnysh, E., Pal, S., Reader, J. M., Uhlmann, W. R., McCain, S., Sanghavi, K., Blasco, D., Brandt, R., Feero, W. G., Ferber, R. A., et al. (2024) · Genetics in Medicine · doi:10.1016/j.gim.2024.101160 · Cited by 11
Self-citationPhysician Communication of Genomic Results in a Diagnostic Odyssey Case Series
Rubanovich, C. K., Cheung, C., Torkamani, A., & Bloss, C. S. (2019) · PEDIATRICS · doi:10.1542/peds.2018-1099i · Cited by 10
Sweet, K. M., Sturm, A. C., Schmidlen, T., Hovick, S. R. A., Peng, J., Manickam, K., Salikhova, A. Y., McElroy, J., Scheinfeldt, L., Toland, A. E., et al. (2016) · Clinical Genetics · doi:10.1111/cge.12820 · Cited by 9
Self-citationFirst Responder to Genomic Information: A Guide for Primary Care Providers
Haga, S. B. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00407-z · Cited by 9
“While some encounters with health providers about DTC results have been reported as satisfying [25], providers have expressed concern about their knowledge to interpret genomic results, the actionability of results, and potential harms to patients [26, 27].”
Elson, S. L., Furlotte, N. A., Hromatka, B. S., Wilson, C. H., Mountain, J. L., Rowbotham, H. M., Varga, E. A., & Francke, U. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1468 · Cited by 6
“Risk is compounded by numerous acquired and situational factors, including oral contraceptive use, hormone replacement therapy (HRT), pregnancy, and prolonged periods of inactivity, among others (Kujovich, 1993b, 1993c; Varga & Kujovich, 2012).”
BackgroundResultThe Healthiest Diet for You: Scientific Aspects
Simopoulos, A. P. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-2734-5 · Cited by 9
The Healthiest Diet for You: Scientific Aspects
Simopoulos, A. P. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-2734-5-1 · Cited by 7
Trottier, M., Green, D., Ovadia, H., Catchings, A., Gruberg, J., Groner, V., Fanjoy, C., Dandiker, S., Blazer, K. R., Hamilton, J. G., et al. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2508 · Cited by 5
“Among those who do share results, many express dissatisfaction with the encounter (van der Wouden et al., 2016), possibly related to inflated marketing promises by CGT companies (Burke & Trinidad, 2016).”
Internet Versus Virtual Reality Settings for Genomics Information Provision
Persky, S., Kistler, W. D., Klein, W. M. P., & Ferrer, R. A. (2019) · Cyberpsychology Behavior and Social Networking · doi:10.1089/cyber.2017.0453 · Cited by 6
“For example, with the increased advertisement of consumer-facing genetic testing services, patients have begun to discuss the relevance and role of genetic information with their providers.(4) In this study, we compare two methods for communicating genomic concepts to the public: Internet-based and virtual reality (VR…”
BackgroundValue of Collaboration among Multi-Domain Experts in Analysis of High-Throughput Genomics Data
Meerzaman, D. M., & Dunn, B. K. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0769 · Cited by 5
“Consumers now rely on primary care health providers to interpret such DTC-obtained genetic results (21, 22).”
BackgroundGenetic counselor approaches to BRCA1/2 direct‐to‐consumer genetic testing results
Burke, S., Mork, M. E., Qualmann, K. J., Woodson, A., Ha, M. J., Arun, B., & Kaulfus, M. (2021) · Journal of Genetic Counseling · doi:10.1002/jgc4.1380 · Cited by 5
“The majority of DTC-GT companies recommend discussion of results with a healthcare provider (Singleton et al., 2012), and consumers most commonly present to their primary care physician (PCP) with questions related to their results (Van der Wouden et al., 2016).”
BackgroundEffect of co-payment on behavioral response to consumer genomic testing
Liu, W. J., Outlaw, J. J., Wineinger, N. E., Boeldt, D. L., & Bloss, C. S. (2018) · Translational Behavioral Medicine · doi:10.1093/tbm/ibx057 · Cited by 5
Hayashi, M., Watanabe, A., Muramatsu, M., & Yamashita, N. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3330-9 · Cited by 4
“[11, 12] and that DTC-type PGT requires tailored follow-up to be effective, few studies have focused on the means of delivering information on DTC-type test results [1].”
BackgroundPersonal genomic screening: How best to facilitate preparedness of future clients
Fleming, J., Terrill, B., Dziadek, M. A., Kirk, E. P., Roscioli, T., & Barlow-Stewart, K. K. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.05.006 · Cited by 4
Kalokairinou, L., Borry, P., & Howard, H. C. (2019) · New Genetics and Society · doi:10.1080/14636778.2019.1677149 · Cited by 4
“…by a longitudinal study among DTC consumers, according to which, while 63% of the 1026 respondents reported that they were planning to share their test results with a healthcare provider, a six-month follow up revealed that only 27% of them had actually done so (van der Wouden et al. 2016).”
BackgroundAssessing the Impact of Developments in Genetic Testing on Insurers' Risk Exposure
Rodriguez-Rincon, D., Parkinson, S., Hocking, L., Evans, H., Hudson, E., & Morley, K. I. (2022) · Rand health quarterly · doi:10.7249/rhq-09-04-05 · Cited by 6
Direct-to-Consumer Genetic Testing: Helping Patients Make Informed Choices
Mahon, S. M. (2018) · Clinical journal of oncology nursing · doi:10.1188/18.cjon.33-36 · Cited by 4
Clinical genetic testing in medical education
Kopel, J. J. (2019) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2018.1528937 · Cited by 3
“As a result, patients are increasingly using personal genetic testing and plan to share their genetic data with their primary care physicians.(3) This is particularly true “when customers face ambiguous or alarming results needing expert interpretation, and they heed the timeless suggestion: ask your health care provi…”
BackgroundNguyen, T. T. M., Ormond, K. E., Weissman, S. M., Kim, H. J., & Reuter, C. M. (2022) · Translational Behavioral Medicine · doi:10.1093/tbm/ibac083 · Cited by 3
Myers, M., & Bloss, C. S. (2020) · JMIR Medical Education · doi:10.2196/21787 · Cited by 3
When Patients Present With Direct-to-Consumer Pharmacogenomic Test Results
Donnelly, R. S., Ayoubieh, H., Kudron, E. L., Mills, R. A., Weiler, T., & Empey, P. E. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.10.016 · Cited by 2
Steijvoort, E. V., Goossens, K., Demesure, K., Stanczak, A., Siermann, M., & Borry, P. (2025) · Open Research Europe · doi:10.12688/openreseurope.19751.1 · Cited by 5
“…that while many participants who discussed their DTC-GT results with primary care professionals or other health care professionals cited health improvement as a key motivation, a substantial proportion expressed concerns about the potential inclusion of genetic results in their medical records 44 .”
InfluentialConsumer-initiated Genetic Testing and Pharmacogenomics
Moyer, A., & Baudhuin, L. (2019) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2019.07.009 · Cited by 3
Perspectives on Consumer and Clinical Genetic Testing Education among Medical Students in West Texas
Kopel, J. J., & Brower, G. L. (2022) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.55729/2000-9666.1050 · Cited by 2
“Greater access to genetic information from these over-the-counter tests has increased the number of patients who want to discuss their results with their primary care physician.(4,5) However, a huge knowledge gap exists among medical students and residents in their ability to interpret and counsel patients on the resu…”
BackgroundDirect-to-Consumer Testing: A New Paradigm for Point-of-Care Testing
Tolan, N. V. (2017) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.0000000000000137 · Cited by 2
“In the current environment, DTC testing may inhibit effective patient care, because many consumers do not share their test results with their healthcare provider.(17) Each of our expert speakers highlight the need for communication of DTC testing results with their healthcare provider, which also serves to promote con…”
BackgroundPace, L. E., Tung, N., Lee, Y. S., Hamilton, J. G., Gabriel, C., Revette, A. C., Raja, S. C., Jenkins, C., Braswell, A., Morgan, K., et al. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06970-8 · Cited by 2
SNP Selection and Concordance in Consumer Genetics TestingPreprint
Thompson, J. F. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/352732 · Cited by 2
The Deceptive Appeal of Direct-to-Consumer Genetics
Mahon, S. M. (2016) · Annals of Internal Medicine · doi:10.7326/l16-0333 · Cited by 1
Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults
Matthys, J. (2016) · Annals of Internal Medicine · doi:10.7326/l16-0283
Preventive genetic testing: our best foot forward
Stewart (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180920ks
Medicine is a data science, we should teach like itPreprint
McGowan, L. D., & Leek, J. T. (2020) · doi:10.31219/osf.io/e8tgp
Online Genetics for Health: An Empirical Investigation of How Users Matter
Khan, S. (2020) · uO Research (University of Ottawa) · doi:10.20381/ruor-24409
“In a study by van der Wouden et al. (2016), 63% of respondents said they would share their results with a healthcare provider; yet, after six months, only 35% had done so (p. 516).”
BackgroundSebastian, A. (2020) · TSpace (University of Toronto)
Linking DTC genome testing with primary care
(2016) · PharmacoEconomics & Outcomes News · doi:10.1007/s40274-016-2874-y
Nephrologists’ Views on a Workflow for Returning Genetic Results to Research Participants
Weiss, R., Rasouly, H. M., Marasà, M., Fernández, H., Lin, F., & Sabatello, M. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.08.026
Cohidon, C., Cardinaux, R., Cornuz, J., Chenal, R., Desvergne, B., Guessous, I., Cerqui, D., & Widmer, D. (2021) · Figshare · doi:10.6084/m9.figshare.14490326
Elective genomic sequencing for adults in research, clinical and commercial contexts
Linderman, M. D., Adelson, S. M., Berro, T. M., Anderson, J. L., Crawford, S. D., Cunningham, T. J., Esplin, E. D., Ewing, A. T., Nielsen, D. E., Pereira, S., et al. (2026) · BMC Medical Genomics · doi:10.1186/s12920-026-02414-6
“It may also suggest that the results were not considered medically actionable by the HCP. Expanding on previous results [18], the fraction of individuals discussing their results with a HCP is higher in this study than reported for DTC genotyping-based testing [38].”
Self-citationPrimary care providers' experiences with and perceptions of personalized genomic medicine.
(2016) · PubMed Central · Cited by 118
Metadata
- Authors
- van der Wouden, C. H., Carere, D. A., Maitland-van der Zee, A. H., Ruffin, M. T., Roberts, J. S., Green, R. C., & for the Impact of Personal Genomics Study Group†*
- Affiliations
- From Brigham and Women's Hospital, the Broad Institute, Harvard Medical School, and Partners HealthCare Personalized Medicine, Boston, Massachusetts; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; McMaster University and Genetic and Molecular Epidemiology Laboratory, Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada; and University of Michigan and University of Michigan School of Public Health, Ann Arbor, Michigan.
- Broad Institute (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2016-04-19
- Volume
- 164
- Issue
- 8
- Pages
- 513-522
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2317111255
- Semantic Scholar
- c9caf8f5420e66a50dafb2cfb73489e0ff967fcf
- Cited by
- 95
- References
- 39
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 8 · 2021: 8 · 2020: 14 · 2019: 18 · 2018: 16 · 2017: 15 · 2016: 8
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- Stichting Jo Kolk Studiefonds
- National Institutes of Health (HD077671)
- Canadian Institutes of Health Research
- National Human Genome Research Institute (R01HG002213, R01HG005092, U01HG006500)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U19HD077671)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Keywords
- direct-to-consumer genetic testing, primary care providers, customer satisfaction, physician engagement, genetic literacy, consumer perception
- MeSH terms
- Direct-To-Consumer Screening and Testing, Adult, Aged, Attitude of Health Personnel, Consumer Behavior, Female, Genetic Testing, Humans, Longitudinal Studies, Male, Middle Aged, Perception, Physician-Patient Relations, Prospective Studies, United States, Genomics, Young Adult, Physicians, Primary Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.